# K252437: JAZZ Spinal System

- Pathway: 510(k) (Special)
- Applicant: Implanet
- Decided: Aug 28, 2025 after 27 days
- Product code: NKB (Thoracolumbosacral Pedicle Screw System)
- Device class: 2
- Regulation: 21 CFR 888.3070
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 21 generations back to K040583 (2004). 370 ancestors in all.
No later device cites it as a predicate yet.
1 of 371 devices in its family (counting itself) has a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K240392: JAZZ Spinal System, Implanet (2024) Summary page 6.
- K230961: Zeus Spinal System, Shanghai Sanyou Medical Co, Ltd. (2023) Summary page 6.

## Indications for use
The JAZZ Spinal System is intended for posterior, non-cervical fixation as an adjunct to fusion for skeletally mature patients for the following indications: degenerative disc disease (defined as back pain of discogenic origin with degeneration of the disc confirmed by history and radiographic studies); spondylolisthesis; trauma (i.e., fracture or dislocation); spinal stenosis; curvatures (i.e., scoliosis, kyphosis and/or lordosis); tumor; pseudarthrosis; and/or failed previous fusion. In addition, when used as a pedicle screw fixation system, the JAZZ Spinal System is intended for skeletally mature patients with severe spondylolisthesis (Grades 3 and 4) of the fifth lumbar-first sacral, L5-S1 vertebra, who are receiving fusion by autogenous bone graft only, who are having the device attached to the lumbar and sacral spine (levels may be from L3 to the sacrum/ilium), who are having the device removed after the attainment of a solid fusion.

Source page: https://510kreport.com/device/K252437
Methodology: https://510kreport.com/methodology